You're missing the fact that this is rather unfortunately a very challenging and costly compound to produce.
Regrettably, it is not what is referred to as a "small molecule" compound, as some suspected it would be and hoped for, that such would be in contrast to GLYX-13 which is a tetrapeptide (not a 'small molecule'). Such compounds are rather expensive to produce in comparison to small molecules. Now not only is NRX-1074 a tetrapeptide, but NRX-1074 is a unique (RE: difficult and costly) conjugated, enantiomeric (always a cost factor again) tetrapeptide, which makes if still further more costly than a simple tetrapeptide such as GLYX-13 is.
Notably, if you wish to get say even 5 people pooled together before the sale ends you can all get 100mg for the 500mg basis of $1320/500mg which is $264/100mg. After the sale ends it will be as per the site ~$1650/500mg and therein $330/100mg. Right now if you just wish to procure 100mg 'alone' it is $320, 20% less ~$400 as on the site, which is valid through Sunday and will NOT be held for a longer period.
Group buys tend to be fraught with issues to note as well, so within we are going out on a limb with this compound to make it available and offer it at a pre-order incentive we are trying to do as best for the community, progressive research, and a quest toward betterment.
Of course this is just for edification purposes and discussion, but to further note due to the potency and dose correlation (efficacy at 5mg to 10mg via i.v. and what appears valid via i.n., and should be about same for i.m./s.c.) and further still even more advantageous, the duration of efficacy that is seen to be 2 weeks from a single administration, it is an inherently a potentially cost effective agent. If it had to be taken daily at the dose basis it would not so much be so, but with a duration noted to be up to about 2 weeks therein creates a cost/dose factor that is quite viable. Note, 7.5mg taken every 2 weeks would be with 100mg an amount lasting about 6 months.
Anyway, we went out on a limb here to note, as we so wanted to make this available, have only been able to go forward due to a generous 'benefactor', have had some of the already limited pre-commitments not follow though, and other challenging issues with this project. However, we are still very pleased to be able to do this and bring this compound forward for progressive research at what we know is a very fair price basis.
Thank you to all for consideration to support progressive research and progress toward betterment.